Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicine company, it uses innovative science and digital technologies to create transformative treatments in areas of great medical need. In its quest to find new medicines, Novartis consistently ranks among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and the company is finding innovative ways to expand access to its latest treatments. About 108,000 people of more than 140 nationalities work at Novartis around the world.
The global impact investing market is worth over $1 trillion. Impact valuation can help businesses measure their social and environmental credentials.
Biopharmaceutical companies can play a big role in addressing health challenges like a cardiovascular disease by strategically partnering with health systems.
Data science and technology can improve human health in all corners of the world for the duration of the pandemic and beyond.
World Economic Forum: Our Centre enables leaders to co-create a new vision on four interconnected areas: economic growth, revival and transformation; work, wages and job creation; educati...
Anticipating how pioneering technologies, innovative business models and new partnerships are transforming businesses and governments’ ability to drive economic and societal impact.The Pl...
The Platform for Shaping the Future of Health and Healthcare engages stakeholders in new models of public private collaboration to identify and scale up solutions for more resilient, effi...
